Michelle Lucatorto
Overview
Explore the profile of Michelle Lucatorto including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
62
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Munro S, Baker D, Giuliano K, Sullivan S, Haber J, Jones B, et al.
Infect Control Hosp Epidemiol
. 2021 Jun;
42(8):991-996.
PMID: 34103108
In 2020 a group of U.S. healthcare leaders formed the National Organization to Prevent Hospital-Acquired Pneumonia (NOHAP) to issue a call to action to address non-ventilator-associated hospital-acquired pneumonia (NVHAP). NVHAP...
2.
Greenstone C, Peppiatt J, Cunningham K, Hosenfeld C, Lucatorto M, Rubin M, et al.
J Gen Intern Med
. 2019 May;
34(Suppl 1):4-6.
PMID: 31098969
No abstract available.
3.
Lambert-Kerzner A, Lucatorto M, McCreight M, Williams K, Fehling K, Peterson J, et al.
Nurse Pract
. 2016 Oct;
41(11):16-24.
PMID: 27764064
The Veterans Health Administration (VHA) is proposing full-practice authority for advanced practice registered nurses (APRNs) to improve access, care delivery, and patient choice, as well as reduce costs. The authors...
4.
Watts S, Lucatorto M
Curr Diab Rep
. 2014 May;
14(7):504.
PMID: 24816751
Primary care has changed remarkably with chronic disease burden growth. Nurse case managers assist with this chronic disease by providing if not significantly better care, than equivalent care to that...
5.
Beard A, Hofer T, Downs J, Lucatorto M, Klamerus M, Holleman R, et al.
Circ Cardiovasc Qual Outcomes
. 2012 Dec;
6(1):66-74.
PMID: 23233749
Background: Performance measures that emphasize only a treat-to-target approach may motivate overtreatment with high-dose statins, potentially leading to adverse events and unnecessary costs. We developed a clinical action performance measure...